Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Venova Medical develops vascular access systems for patients requiring renal replacement therapy.
Terminal X - Your AI Investment Agent
Curated Local Discovery Platform
Saige Research specializes in artificial intelligence solutions for industrial inspection and quality control.
Endorobotics is a healthcare centre that offers endoscopic surgery services.
Inno Ray is a technology company that develops and commercializes lasers and laser equipment.
Vyriad is a clinical stage biopharmaceutical company.
Playad.ai develops an AI-native marketing platform for multi-agent ad workflows and interactive ad creatives.
Flatdis is a corporation that specializes in naval engine control equipment and ship maintenance.
AITRICS delivers AI-powered medical software designed to support clinicians in detecting and preventing critical patient deterioration.
CLE provides software packages, scanning, 3D reconstruction, and modeling services for factory automation.
Qum Therapeutics Develops immunotherapies that target pathogenic cells and engage the patient’s immune system to control disease.
VESSL AI is a neo-cloud company operating VESSL Cloud, a GPU cloud for AI workloads (A100, H100, B200, B300, GB200).
Delivers unmatched performance, density, & ultra-low latency at scale, w/out the cost & complexity of traditional storage via nextgen flash
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
RLWRLD is a software company that develops foundation models through Artificial Intelligence and robotics.
PersonaAI is a conversational AI technology company that provides chatbot, callboat and AI semiconductor Kiosk product and SaaS products.
BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.
Payhere is a fintech company that provides card terminals and online payment gateway services for multiple industries.
Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases.
WorkerInSpace is a company specializing in on-orbit servicing and space production.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
S-Alpha Therapeutics engages in the research and development of health apps and digital therapeutics.
Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
Mirae Asset has invested in 196 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Mirae Asset's top investment sectors include Health Care, Information Technology, Artificial Intelligence (AI), Biotechnology, Therapeutics. The firm invests across 48 different industry categories.
Among tracked funding rounds, 4D Molecular Therapeutics received $100.0M in a Post Ipo Equity round. Mirae Asset's total known invested capital is $3.7B.
Mirae Asset's average investment size is $94.2M across its portfolio of 196 companies.
Recent Mirae Asset portfolio additions include Venova Medical, Project Pluto, Daytrip, Saige Research, Endorobotics. These companies were founded in 2020 or later.